United States · FDA National Drug Code directory
Danazol
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-862_9e103cf9-f075-48ba-8913-2e44f9442781
- Product NDC
- 71205-862
- Form
- CAPSULE
- Composition / generic term
- Danazol
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20050928
- Source listing expiry
- 20261231
Source-listed ingredients
- DANAZOL — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (71205-862-00) · 71205-862-00
- 30 CAPSULE in 1 BOTTLE (71205-862-30) · 71205-862-30
- 500 CAPSULE in 1 BOTTLE (71205-862-55) · 71205-862-55
- 60 CAPSULE in 1 BOTTLE (71205-862-60) · 71205-862-60
- 120 CAPSULE in 1 BOTTLE (71205-862-72) · 71205-862-72
- 90 CAPSULE in 1 BOTTLE (71205-862-90) · 71205-862-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →